Inflazome (part of Roche) Company
.png)
Inflazome is a biotech company that develops orally available drugs to address inflammatory diseases by targeting inflammasomes. The company's drugs block inflammasome signals, eliminating a root cause of inflammation, enabling healthcare institutions to avail targeted therapies for inflammatory diseases such as Parkinson's, Alzheimer's, atherosclerosis, and type 2 diabetes. The company was incorporated in 2016 and is headquartered in Dublin, Ireland.
Industry:
Geroscience
Headquarters:
Dublin, Dublin, Ireland
Zip:
11-50
Founded Date:
2016-01-01
Employees Number:
11-50
Acquisitions Number:
4
Investors Number:
63822007
Total Funding:
$1M to $10M
Estimated Revenue:
2020-09-21
Last Funding Date:
Grant
Last Funding Type:
info@inflazome.com
Register and Claim Ownership